The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination
- PMID: 23081796
- DOI: 10.1002/hep.26097
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination
Abstract
Scavenger receptor class B type I (SR-BI) is a high-density lipoprotein (HDL) receptor highly expressed in the liver and modulating HDL metabolism. Hepatitis C virus (HCV) is able to directly interact with SR-BI and requires this receptor to efficiently enter into hepatocytes to establish productive infection. A complex interplay between lipoproteins, SR-BI and HCV envelope glycoproteins has been reported to take place during this process. SR-BI has been demonstrated to act during binding and postbinding steps of HCV entry. Although the SR-BI determinants involved in HCV binding have been partially characterized, the postbinding function of SR-BI remains largely unknown. To uncover the mechanistic role of SR-BI in viral initiation and dissemination, we generated a novel class of anti-SR-BI monoclonal antibodies that interfere with postbinding steps during the HCV entry process without interfering with HCV particle binding to the target cell surface. Using the novel class of antibodies and cell lines expressing murine and human SR-BI, we demonstrate that the postbinding function of SR-BI is of key impact for both initiation of HCV infection and viral dissemination. Interestingly, this postbinding function of SR-BI appears to be unrelated to HDL interaction but to be directly linked to its lipid transfer function.
Conclusion: Taken together, our results uncover a crucial role of the SR-BI postbinding function for initiation and maintenance of viral HCV infection that does not require receptor-E2/HDL interactions. The dissection of the molecular mechanisms of SR-BI-mediated HCV entry opens a novel perspective for the design of entry inhibitors interfering specifically with the proviral function of SR-BI.
Copyright © 2012 American Association for the Study of Liver Diseases.
Similar articles
-
High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein.J Virol. 2007 Aug;81(15):8063-71. doi: 10.1128/JVI.00193-07. Epub 2007 May 16. J Virol. 2007. PMID: 17507483 Free PMC article.
-
The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.Biochemistry. 2003 Jun 24;42(24):7527-38. doi: 10.1021/bi026949a. Biochemistry. 2003. PMID: 12809509
-
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.Hepatology. 2007 Dec;46(6):1722-31. doi: 10.1002/hep.21994. Hepatology. 2007. PMID: 18000990
-
Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis.Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1732-8. doi: 10.1161/01.ATV.0000091363.28501.84. Epub 2003 Aug 14. Arterioscler Thromb Vasc Biol. 2003. PMID: 12920050 Review.
-
Signaling by the high-affinity HDL receptor scavenger receptor B type I.Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):144-50. doi: 10.1161/ATVBAHA.109.196170. Arterioscler Thromb Vasc Biol. 2010. PMID: 20089950 Review.
Cited by
-
Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.Sci Rep. 2018 Oct 19;8(1):15486. doi: 10.1038/s41598-018-33861-6. Sci Rep. 2018. PMID: 30341327 Free PMC article.
-
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.J Virol. 2019 Oct 29;93(22):e00810-19. doi: 10.1128/JVI.00810-19. Print 2019 Nov 15. J Virol. 2019. PMID: 31462563 Free PMC article.
-
The ins and outs of hepatitis C virus entry and assembly.Nat Rev Microbiol. 2013 Oct;11(10):688-700. doi: 10.1038/nrmicro3098. Epub 2013 Sep 10. Nat Rev Microbiol. 2013. PMID: 24018384 Free PMC article. Review.
-
Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.J Virol. 2018 Mar 28;92(8):e02258-17. doi: 10.1128/JVI.02258-17. Print 2018 Apr 15. J Virol. 2018. PMID: 29437969 Free PMC article.
-
New perspectives for preventing hepatitis C virus liver graft infection.Lancet Infect Dis. 2016 Jun;16(6):735-745. doi: 10.1016/S1473-3099(16)00120-1. Lancet Infect Dis. 2016. PMID: 27301929 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials